InsiderTrades

Form 4 for PODD Insulet Corporation

Accepted 2021-07-02 00:00:00 ET · period of report 2021-05-14 · accession 0001127602-21-021212 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2021-07-02 2021-05-14 PODD Petrovic Shacey Pres, CEO, Dir G - Gift $0.00 +25.9K 25.9K New $0
D 2021-07-02 2021-05-14 PODD Petrovic Shacey Pres, CEO, Dir G - Gift $0.00 -25.9K 15.7K -62% $0
D 2021-07-02 2021-07-01 PODD Petrovic Shacey Pres, CEO, Dir M - OptEx $30.58 +15.0K 30.8K +95% +$458.7K
D 2021-07-02 2021-07-01 PODD Petrovic Shacey Pres, CEO, Dir S - Sale+OE $278.56 -15.0K 15.8K -49% -$4.18M
D 2021-07-02 2021-07-01 PODD Petrovic Shacey Pres, CEO, Dir M - OptEx $0.00 -15.0K 7,436 -67% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-05-14 G A 25,905 $0.00 25,905 I — — (F1) On May 14, 2021, the reporting person gifted 25,905 shares of Insulet common stock to a family trust of which the reporting person is the settlor and a trustee. The beneficiaries of the trust are members of the reporting person's immediate family.
2 Common Common Stock 2021-05-14 G D 25,905 $0.00 15,684 D By SP Trust — — (F1) On May 14, 2021, the reporting person gifted 25,905 shares of Insulet common stock to a family trust of which the reporting person is the settlor and a trustee. The beneficiaries of the trust are members of the reporting person's immediate family.
3 Common Common Stock 2021-07-01 M A 15,000 $30.58 30,779 D — — (F2) The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. (F3) Includes 95 shares acquired under the Insulet Corporation Employee Stock Purchase Plan on May 28, 2021.
4 Common Common Stock 2021-07-01 S D 15,000 $278.56 15,779 D — — (F2) The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. (F4) The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $274.695 to $280.55. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
5 Derivative Employee Stock Option (Right to Buy) 2021-07-01 M D 15,000 $0.00 7,436 D $30.58 · — to 2025-02-09 15,000 Common Stock (F5) This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.